Prosecution Insights
Last updated: August 18, 2026

Examiner: THOMAS, TIMOTHY P

Tech Center 1600 • Art Units: 1611 1614 1628

This examiner grants 26% of resolved cases

Performance Statistics

26.4%
Allow Rate
-33.6% vs TC avg
958
Total Applications
+38.1%
Interview Lift
1351
Avg Prosecution Days
Based on 910 resolved cases, 2023–2026

Rejection Statute Breakdown

2.7%
§101 Eligibility
16.6%
§102 Novelty
39.4%
§103 Obviousness
26.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19191890 LOW-SORBING GLYBURIDE FORMULATION AND METHODS Final Rejection REMEDY PHARMACEUTICALS, INC.
17633973 ENZYME INHIBITORS Non-Final OA KALVISTA PHARMACEUTICALS LIMITED
17921540 SOLID AND LIQUISOLID FORMULATIONS OF CORALLOPYRONIN A Final Rejection RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month